Now live: Pro — the full 13F research suite for serious investorsSee pricing →
SB INVESTMENT ADVISERS (UK) LTD

Q2 2024 · 13F-HR

SB INVESTMENT ADVISERS (UK) LTDholdings as filed

Filed 2024-08-14 · accession 0001493152-24-031809

$10.82B
Reported value
12
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
22266T109CPNGCOUPANG INC$7.32B67.7%349,542,259CommonSOLE
G4124C109GRABGRAB HOLDINGS LIMITED$1.43B13.2%401,796,672CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$754.3M6.97%71,361,388CommonSOLE
25809K105DASHDOORDASH INC$510.3M4.72%4,691,255CommonSOLE
20464U100COMPCOMPASS INC$272.1M2.51%75,570,273CommonSOLE
75943R102RLAYRELAY THERAPEUTICS INC$181.9M1.68%27,904,963CommonSOLE
92764N102VIRVIR BIOTECHNOLOGY INC$148.5M1.37%16,684,041CommonSOLE
051774107AURAURORA INNOVATION INC$109.2M1.01%39,417,358CommonSOLE
35969L108YMMFULL TRUCK ALLIANCE CO LTD$67.0M0.62%8,332,557CommonSOLE
29280W109NRGVENERGY VAULT HOLDINGS INC$17.6M0.16%18,535,631CommonSOLE
37611X100DNA4EURGINKGO BIOWORKS HOLDINGS INC$8.2M0.08%24,429,191CommonSOLE
37427G101GETRGETAROUND INC$3.0M0.03%21,516,384CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.